HB0373 (CH0475)

Find a 2017 Bill:

2017 Regular Session

 

Entitled:

Biotechnology Investment Tax Credit - Qualified Maryland Biotechnology Company - Definition

Sponsored by:

Delegate Barnes, D.

Status:

Approved by the Governor - Chapter 475


Synopsis:Altering the definition of "qualified Maryland biotechnology company" to extend a specified period of time from a specified date that an active business may claim the biotechnology tax credit; altering the definition of "biotechnology company" to include a company that will be primarily engaged in, or within 2 months will be primarily engaged in, specified activities; providing for the revocation of a specified tax credit certificate and the recapture of the tax credit under specified circumstances; etc.
Analysis:Fiscal and Policy Note (Revised)
All Sponsors:Delegates D. Barnes, Afzali, Brooks, Buckel, Carr, Chang, Ciliberti, Fennell, Folden, Gilchrist, Gutierrez, Haynes, C. Howard, Knotts, Krimm, McConkey, McKay, Metzgar, Platt, Reznik, Shoemaker, Simonaire, Tarlau, Turner, Vogt, M. Washington, and C. Wilson
Additional Facts:Cross-filed with: SB0226
Introduced in a prior session as: HB1554 Session: 2016 Regular Session
Bill File Type: Regular
Effective Date(s): June 1, 2017
Committee(s):
Ways and Means  View Committee HearingBudget and Taxation  View Committee Hearing
Broad Subject(s):Taxes - Income
Narrow Subject(s):Industry and Technology
Investments -see also- Securities
Medical Research
Tax Credits
Statutes:Article - Tax - General
(10-725)

How a Bill Becomes Law

Legislative Lingo

Explanation of Floor Motions and Actions


November 28, 2017 12:59 P.M.